Stock Earnings

Question 1

Novartis AG'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Novartis AG'in toplam varlıkları $102,246 olup, net profit $11,941'dir.

Question 2

NVS'ün temel finansal oranları nelerdir?

Accepted Answer

Novartis AG'in cari oranı 1.75, net kâr marjı 23.08, hisse başına satış $25.41'dir.

Question 3

Novartis AG'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Novartis AG largest revenue segment is Other, at a revenue of 1,405,000,000 in the most earnings release.For geography, United States Revenue (Post-Q2 2023 Reporting) is the primary market for Novartis AG, at a revenue of 21,146,000,000.

Question 4

Novartis AG kârlı mı?

Accepted Answer

yes, son mali tablolara göre Novartis AG'in net profit $11,941'dir.

Question 5

Novartis AG'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Novartis AG'in yükümlülüğü 58,200'dir.

Question 6

Novartis AG'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Novartis AG'in toplam tedavüldeki hisse sayısı 1,975.08'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	56,024	51,722	46,660	43,375	43,974	49,898
Revenue Growth (YoY)	12%	11%	8%	-1%	-12%	3%
Cost of Revenue	13,392	12,815	12,020	11,211	11,391	14,400
Gross Profit	42,632	38,907	34,640	32,164	32,583	35,498
Selling, General & Admin	13,303	12,564	12,489	12,193	12,756	14,093
Research & Development	10,034	9,302	8,600	9,378	8,150	8,484
Operating Expenses	24,081	22,587	21,998	21,958	21,620	23,179
Other Non Operating Income (Expenses)	107	-85	-60	-115	-108	-128
Pretax Income	16,419	13,640	9,123	7,177	24,530	9,878
Income Tax Expense	2,036	1,701	551	1,128	1,625	1,807
Net Income	14,393	11,941	14,850	6,955	24,021	8,072
Net Income Growth	-18%	-20%	113.99%	-71%	198%	-31%
Shares Outstanding (Diluted)	1,940	2,035	2,092	2,197	2,260	2,296
Shares Change (YoY)	-4%	-3%	-5%	-3%	-2%	-1%
EPS (Diluted)	7.41	5.87	7.09	3.16	10.62	3.52
EPS Growth	-15%	-17%	124%	-70%	202%	-30%
Free Cash Flow	17,059	13,805	11,705	11,565	12,100	11,065
Free Cash Flow Per Share	8.79	6.78	5.59	5.26	5.35	4.81
Gross Margin	76.09%	75.22%	74.23%	74.15%	74.09%	71.14%
Operating Margin	33.11%	31.55%	27.09%	23.52%	24.93%	24.68%
Profit Margin	25.69%	23.08%	31.82%	16.03%	54.62%	16.17%
Free Cash Flow Margin	30.44%	26.69%	25.08%	26.66%	27.51%	22.17%
EBITDA	23,953	20,919	20,919	17,387	17,076	18,783
EBITDA Margin	42.75%	40.44%	44.83%	40.08%	38.83%	37.64%
D&A For EBITDA	5,402	4,599	8,277	7,181	6,113	6,464
EBIT	18,551	16,320	12,642	10,206	10,963	12,319
EBIT Margin	33.11%	31.55%	27.09%	23.52%	24.93%	24.68%
Effective Tax Rate	12.4%	12.47%	6.03%	15.71%	6.62%	18.29%

Novartis AG (NVS) Price

NVS Stock Price Chart

NVS Income

Follow-Up Questions